Comparing the effect of clopidogrel versus ticagrelor on coronary microvascular dysfunction in acute coronary syndrome patients (TIME trial): Study protocol for a randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Park, Sang Don ^a   Baek, Yong Soo ^a   Woo, Seong Ill ^a   Kim, Soo Han ^a   Shin, Sung Hee ^a   Kim, Dae Hyeok ^a   Kwan, Jun ^a   Park, Keum Soo ^a  

^a Inha University Hospital   (South Korea)

Author keywords

Antiplatelet agents; MeSH terms; Microcirculation; Myocardial infarction

Indexed keywords

CLOPIDOGREL; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

ADULT; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY VASCULAR RESISTANCE; ECHOCARDIOGRAPHY; FOLLOW UP; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPEN STUDY; PARALLEL DESIGN; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ACUTE CORONARY SYNDROME; ANALOGS AND DERIVATIVES; CLINICAL PROTOCOL; COMPARATIVE STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; DRUG EFFECTS; ECHOGRAPHY; METHODOLOGY; MICROCIRCULATION; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; SOUTH KOREA; TIME; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ADENOSINE; CLINICAL PROTOCOLS; CORONARY CIRCULATION; CORONARY VESSELS; HUMANS; MICROCIRCULATION; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RESEARCH DESIGN; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84901465483     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-151     Document Type: Article

References (34)

1. Sosnowski C. Commentary to the article: Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM; TRITON-TIMI 38 Investigators: Prasugrel versus clopidogrel in patients with acute coronary syndrome. N Engl J Med 2007; 357: 2001-15. Kardiol Pol 2008, 66(2):222-225.
2. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsén M., PLATO Investigators Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009, 361(11):1045-1057. 10.1056/NEJMoa0904327, 19717846, PLATO Investigators.
3. Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009, 120(25):2577-2585. 10.1161/CIRCULATIONAHA.109.912550, 19923168.
4. van Giezen JJ, Sidaway J, Glaves P, Kirk I, Bjorkman JA. Ticagrelor inhibits adenosine uptake in vitro and enhances adenosine-mediated hyperemia responses in a canine model. J Cardiovasc Pharmacol Ther 2012, 17(2):164-172. 10.1177/1074248411410883, 21697355.
5. Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, Gariboldi V, Condo J, Thuny F, Frere C, Camoin-Jau L, Paganelli F, Dignat-George F, Guieu R. Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome. J Am Coll Cardiol 2014, 63(9):872-877. 10.1016/j.jacc.2013.09.067, 24291273.
6. Reffelmann T, Kloner RA. Microvascular alterations after temporary coronary artery occlusion: the no-reflow phenomenon. J Cardiovasc Pharmacol Ther 2004, 9(3):163-172. 10.1177/107424840400900303, 15378136.
7. Reffelmann T, Kloner RA. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 2006, 101(5):359-372. 10.1007/s00395-006-0615-2, 16915531.
8. Kunichika H, Ben-Yehuda O, Lafitte S, Kunichika N, Peters B, DeMaria AN. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study. J Am Coll Cardiol 2004, 43(2):276-283. 10.1016/j.jacc.2003.08.040, 14736449.
9. de Lemos JA, Antman EM, Gibson CM, McCabe CH, Giugliano RP, Murphy SA, Coulter SA, Anderson K, Scherer J, Frey MJ, Van der Wieken R, Van de Werf F, Braunwald E. Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial. Circulation 2000, 101(3):239-243. 10.1161/01.CIR.101.3.239, 10645918.
10. Morrow DA, Wiviott SD, White HD, Nicolau JC, Bramucci E, Murphy SA, Bonaca MP, Ruff CT, Scirica BM, McCabe CH, Antman EM, Braunwald E. Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction. Circulation 2009, 119(21):2758-2764. 10.1161/CIRCULATIONAHA.108.833665, 19451347.
11. Fearon WF, Shah M, Ng M, Brinton T, Wilson A, Tremmel JA, Schnittger I, Lee DP, Vagelos RH, Fitzgerald PJ, Yock PG, Yeung AC. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2008, 51(5):560-565. 10.1016/j.jacc.2007.08.062, 18237685.
12. McGeoch R, Watkins S, Berry C, Steedman T, Davie A, Byrne J, Hillis S, Lindsay M, Robb S, Dargie H, Oldroyd K. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 2010, 3(7):715-722.
13. Fearon WF, Balsam LB, Farouque HM, Caffarelli AD, Robbins RC, Fitzgerald PJ, Yock PG, Yeung AC. Novel index for invasively assessing the coronary microcirculation. Circulation 2003, 107(25):3129-3132. 10.1161/01.CIR.0000080700.98607.D1, 12821539.
14. Fearon WF, Nakamura M, Lee DP, Rezaee M, Vagelos RH, Hunt SA, Fitzgerald PJ, Yock PG, Yeung AC. Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA Study). Circulation 2003, 108(13):1605-1610. 10.1161/01.CIR.0000091116.84926.6F, 12963639.
15. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation 2006, 113(17):2054-2061. 10.1161/CIRCULATIONAHA.105.603522, 16636168.
16. Yong AS, Ho M, Shah MG, Ng MK, Fearon WF. Coronary microcirculatory resistance is independent of epicardial stenosis. Circ Cardiovasc Interv 2012, 5(1):103-108. S1-S2, 10.1161/CIRCINTERVENTIONS.111.966556, 22298800.
17. Verhoeff BJ, van de Hoef TP, Spaan JA, Piek JJ, Siebes M. Minimal effect of collateral flow on coronary microvascular resistance in the presence of intermediate and noncritical coronary stenoses. Am J Physiol Heart Circ Physiol 2012, 303(4):H422-H428. 10.1152/ajpheart.00003.2012, 22730389.
18. Layland J, Carrick D, McEntegart M, Ahmed N, Payne A, McClure J, Sood A, McGeoch R, MacIsaac A, Whitbourn R, Wilson A, Oldroyd K, Berry C. Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 2013, 6(3):231-236. 10.1161/CIRCINTERVENTIONS.112.000180, 23756697.
19. Fearon WF, Low AF, Yong AS, McGeoch R, Berry C, Shah MG, Ho MY, Kim HS, Loh JP, Oldroyd KG. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation 2013, 127(24):2436-2441. 10.1161/CIRCULATIONAHA.112.000298, 23681066.
20. Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54(4):281-292. 10.1016/j.jacc.2009.03.054, 19608025.
21. Lerman A, Holmes DR, Herrmann J, Gersh BJ. Microcirculatory dysfunction in ST-elevation myocardial infarction: cause, consequence, or both?. Eur Heart J 2007, 28(7):788-797. 10.1093/eurheartj/ehl501, 17347176.
22. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004, 109(9):1121-1126. 10.1161/01.CIR.0000118496.44135.A7, 14967718.
23. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, Wohrle J, Kestler HA. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005, 26(6):549-557.
24. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002, 105(16):1909-1913. 10.1161/01.CIR.0000014683.52177.B5, 11997276.
25. Sardella G, Mancone M, Bucciarelli-Ducci C, Agati L, Scardala R, Carbone I, Francone M, Di Roma A, Benedetti G, Conti G, Fedele F. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol 2009, 53(4):309-315. 10.1016/j.jacc.2008.10.017, 19161878.
26. Claeys MJ, Bosmans J, De Ceuninck M, Beunis A, Vergauwen W, Vorlat A, Vrints CJ. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004, 94(1):9-13. 10.1016/j.amjcard.2004.03.021, 15219500.
27. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005, 45(11):1775-1780. 10.1016/j.jacc.2005.02.061, 15936605.
28. Tsujita K, Shimomura H, Kawano H, Hokamaki J, Fukuda M, Yamashita T, Hida S, Nakamura Y, Nagayoshi Y, Sakamoto T, Yoshimura M, Arai H, Ogawa H. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004, 94(4):481-484. 10.1016/j.amjcard.2004.05.007, 15325934.
29. Gurbel PA, Bliden KP, Hiatt BL, O'Connor CM. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 2003, 107(23):2908-2913. 10.1161/01.CIR.0000072771.11429.83, 12796140.
30. Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Bhatt DL, Topol EJ. Variability in platelet responsiveness to clopidogrel among 544 individuals. J Am Coll Cardiol 2005, 45(2):246-251. 10.1016/j.jacc.2004.09.067, 15653023.
31. Bonello L, Tantry US, Marcucci R, Blindt R, Angiolillo DJ, Becker R, Bhatt DL, Cattaneo M, Collet JP, Cuisset T, Gachet C, Montalescot G, Jennings LK, Kereiakes D, Sibbing D, Trenk D, Van Werkum JW, Paganelli F, Price MJ, Waksman R, Gurbel PA., Working Group on High On-Treatment Platelet Reactivity Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol 2010, 56(12):919-933. 10.1016/j.jacc.2010.04.047, 20828644, Working Group on High On-Treatment Platelet Reactivity.
32. Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, Ongini E, Baker SP, Belardinelli L. A2A-adenosine receptor reserve for coronary vasodilation. Circulation 1998, 98(7):711-718. 10.1161/01.CIR.98.7.711, 9715864.
33. Iwamoto T, Umemura S, Toya Y, Uchibori T, Kogi K, Takagi N, Ishii M. Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. Biochem Biophys Res Commun 1994, 199(2):905-910. 10.1006/bbrc.1994.1314, 8135838.
34. Cohen MV, Downey JM. Adenosine at reperfusion: a conundrum ready to be resolved. J Am Coll Cardiol 2009, 53(8):718-719. 10.1016/j.jacc.2008.11.016, 19232906.